Cardiac Rhythm Management
Banner Atricure 2016 sts

 

Activity Description

The webcast is comprised of the proceedings from the accredited satellite symposium held in conjunction with the STS 52nd Annual Meeting, Why the LAA Matters: The Role of LAA Occlusion for Stroke Management. The presentation format consists of synched audio and HD video, along with the presenter’s slides, and features panel discussion sessions.

Cardiac Rhythm Management

Access Presentation

Access Webcast

Click on the session title listed below to view each presentation.

For those wishing to obtain your continuing medical education certification, access Earn CME Credit Tab at the conclusion of the webcast; select the appropriate answer to each posttest question, and successfully obtain the passing score as designated at the top of the test.

AtricCure-STS16-Marc-Gillinov-pres

Welcome and Opening Remarks

Marc Gillinov, MD

play-webcast

AtricCure-STS16-Gorav-Ailawadi-pres

AtriClip: Results of Clinical Trial

Gorav Ailawadi, MD

play-webcast

AtriCure-STS16-Mark-Gendisch-pres

LAA Occlusion for Reducing Stroke Rates and Evaluating Optimal Strategies for Post Op AF Patients

Marc Gerdisch, MD, FACS, FACC

play-webcast

AtriCure-STS16-Mubashir-Mumtaz-pres

Surgical Left Atrial Appendage Closure

Mubashir Mumtaz, MD, FACS, FACC

play-webcast

AtriCure-STS16-panel

Panel Discussion

Moderator: Marc Gillinov, MD
Panel: Gorav Ailawadi, MD, Marc Gerdisch, MD, FACS, FACC, Mubashir Mumtaz, MD, FACS, FACC

play-webcast

Cardiac Rhythm Management

Commercial Supporter

This activity is supported by an educational grant from AtriCure

Sponsor

MediaSphere Medical, LLC and Cine-Med

 

Faculty

Program Chair

AtricCure-STS16-Marc-Gillinov-port

Marc Gillinov, MD
Surgical Director of the Center for Atrial Fibrillation
Cleveland Clinic
Cleveland, OH

Faculty

AtricCure-STS16-Gorav-Ailawadi-port

Gorav Ailawadi, MD
Associate Professor of Surgery
University of Virginia Health System
Charlottesville, VA

AtriCure-STS16-Mark-Gendisch-port

Marc Gerdisch, MD, FACS, FACC
Chief of Cardiovascular and Thoracic Surgery
St. Francis Heart Center
Indianapolis, IN

AtriCure-STS16-Mubashir-Mumtaz-port

Mubashir Mumtaz, MD, FACS, FACC
Chief of Cardiovascular and Thoracic Surgery
Pinnacle Health
Harrisburg, PA

 

CME Information

CME Released: 2/10/2016; Valid for credit through 2/10/2017

Target Audience

This activity has been developed to meet the educational needs of cardiothoracic surgeons, residents, and other physicians and associated healthcare professionals.

Activity Goal

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Evaluate systemic thromboembolization and the role of the LAA in patients with atrial fibrillation.
  • Examine clinical trial outcomes data and apply study results into daily practice.
  • Review minimally invasive therapeutic options to manage the LAA.
  • Assess optimal LAA occlusion clinical decision making strategies and procedural approaches.

Accreditation Statement

This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint-providership of Ciné-Med and MediaSphere Medical. Ciné-Med is accredited by the ACCME to provide continuing medical education for Physicians and is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Ciné-Med designates this educational activity for a maximum of 1AMA PRA CATEGORY 1 Credit(s).
Physicians should only claim credit commensurate with the extent of their participation in the activity.

Ciné-Med designates this activity for 1 Contact Hour for Nurses.

Disclosure Summary

MediaSphere Medical and Cine-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. All Cine-Med and MediaSphere Medical employees and planners in control of content have indicated that they have no relevant financial relationships to disclose.

Dr. Gorav Ailawadi – Speaker: AtriCure; Consultant: Abbott, Edwards, and St. Jude Medical.

Dr. Marc Gerdisch – Instructor / Consultant: AtriCure.

Dr. Marc Gillinov – Consultant: AtriCure

Dr. Mubashir Mumtaz – Faculty, Speaker, Research, Consultant, Advisor: Edwards, Abbott, Medtronic, and AtriCure.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on the title page; physicians and nurses should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™ or Contact Hours, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. Review the educational presentations
  3. Select the appropriate answer to each posttest question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

Provider Contact Information

For technical support or CME/CE questions regarding this activity, please email us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Hardware/Software Requirements:

  • A computer with an Internet connection.
  • Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser.
  • Adobe Flash Player and/or an HTML5 capable browser may be required for video or audio playback.
  • Occasionally other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

MediaSphere protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MediaSphere and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. MediaSphere maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2016 by MediaSphere Medical. All rights reserved. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from MediaSphere Medical.

CME/CE Test

CME/CE Test
  1. Why the LAA Matters: The Role of LAA Occlusion for Stroke Management.
  2. Please enter your information, and complete the following CME post test and evaluation form. Upon successful completion, your submission will be reviewed and you will receive notification shortly regarding the status of your certificate. You must achieve a minimum score of 70% to earn credit for this activity.

  3. First Name: *  
    Invalid Input
  4. Last Name: *  
    Invalid Input
  5. Primary Email Address: *  
    Invalid Input
  6. Confirm Your Email: *  
    Invalid Input
  7. Degree: *  
    Invalid Input
  8. Institution: *  
    Invalid Input
  9. Mailing Address:*  
    Invalid Input
  10. City: *  
    Invalid Input
  11. State: *  
    Invalid Input

  12. 1. The CHA2DS2-VASc risk assessment tool, which identifies ‘major’ and ‘clinically relevant non-major’ risk factors to evaluate ischemic stroke risk in patients with Atrial Fibrillation, which of the following is classified as risk criteria?
  13. Select one*  







    Invalid Input Please Select one

  14. 2. An elevated CHA2DS2-VASc score is a very sensitive indicator for risk of stroke in patients with AF, as well as risk for developing AF?
  15. Select one*  


    Invalid Input Please Select one

  16. 3. Closure of the LAA reduces the incidence of stroke associated with AF, and no potential side-effects exist with closing the LAA?
  17. Select one*  


    Invalid Input Please Select one

  18. 4. When examining the prevalence, impact, and economic implications of AF in stroke, “unless action is taken to improve detection of AF and reduce its consequences, a considerable increase in the social and economic burden associated with AF-related stroke is likely.”
  19. Select one*  


    Invalid Input Please Select one

  20. 5. Which of the following statement is accurate, based upon conclusions from the presentation, LAA Occlusion for Reducing Stroke Rates and Evaluating Optimal Strategies for Post Op AF Patients?
  21. Select one*  






    Invalid Input Please Select one

  22. 6. Data from EXCLUDE, a prospective, multi-center, non-randomized single armed trial, evaluating the procedural safety and efficacy of LAA exclusion, concluded a high rate of procedural success with no safety issues?
  23. Select one*  


    Invalid Input Please Select one

  24. 7. Dr. Mubashir Mumtaz, as summarized in the presentation, Surgical Left Atrial Appendage Closure, has performed 337 clips since 2010 at his center, with another 50,000 plus having been performed worldwide. The following statement is accurate concerning surgical appendage procedural outcomes when employing the clip.
  25. Select one*  





    Invalid Input Please Select one

  26. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  27. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  28. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  29. I would consider my level of expertise in the subject matter after the activity
    Invalid Input

  30. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  31. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  32. Evaluate systemic thromboembolization and the role of the LAA in patients with atrial fibrillation.
    Invalid Input Please Select one

  33. Examine clinical trial outcomes data and apply study results into daily practice.
    Invalid Input Please Select one

  34. Review minimally invasive therapeutic options to manage the LAA.
    Invalid Input Please Select one

  35. Assess optimal LAA occlusion clinical decision making strategies and procedural approaches.
    Invalid Input

  36. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  37. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  38. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  39. Enhanced my current knowledge base:
    Invalid Input Please Select one

  40. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  41. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  42. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  43. Addressed a professional practice gap:
    Invalid Input Please Select one

  44. Was free of commercial bias/influence:
    Invalid Input Please Select one

  45. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  46. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  47. (*) Required Fields
  48. Invalid Input

Cardiac Rhythm Management